5-aminolevulinic acid hydrochloride
Antineoplastic and immunomodulating agents (L01)Antineoplastic and immunomodulating agents (L01) compound in photonamic GmbH &'s portfolio. Molecular target: DNA.
- Target
- DNA
- Mechanism
- DNA inhibitor
pharma · Colorectal Carcinoma · Glioblastoma
photonamic GmbH &
Photonamic GmbH & Co. KG
photonamic GmbH & drug portfolio — 3 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Pinneberg, DE HQ
2002 Founded
26 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Pinneberg, DE
- Founded
- 2002
- Employees
- 26
- Programs
- 2
- Drugs
- 3
- Patents
- 0
photonamic GmbH & pipeline
Portfolio lens on 3 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
photonamic GmbH & drug portfolio — 3 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
Development asset linked to photonamic GmbH & in public FDA and regional records.
-
Development asset linked to photonamic GmbH & in public FDA and regional records.